Skip to content

Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT

Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07055711
Enrollment
45
Registered
2025-07-09
Start date
2025-03-03
Completion date
2025-09-01
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Neuropathy

Brief summary

This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Interventions

DIAGNOSTIC_TESTPeripheral Neuropathic Pain

to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Sponsors

Superior University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

* Females who have completed chemotherapy at least o1 year prior to study. * Aged 29-51. * Females who is currently employed. * Females who have done chemotherapy for stage 1,2,3. * Females who underwent chemotherapy cycles 6-8. * Females who are willing to participate in the study

Exclusion criteria

* Females suffering from psychiatric conditions such as anxiety and depression. * Females suffering from diabetes. * Females who have active cancer. * Females with mastectomy. * Absent from treatment for more than 2 weeks will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Douleur Neuropathique 4 (DN4) Questionnaire6 MonthThe DN4 questionnaire is used to assess the neuropathic pain, if the score is \> 4 it indicates the neuropathic pain is present while \<3 than is unlikely.
visual analog scale6 MonthsThe visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and \> 75 is consider as severe pain.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026